OrphanDrug
OrphanDrug
Pharma Knowledge Base

Hall-Riggs syndrome

MeSH: C535623ORPHA: 2107

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Hall-Riggs syndrome is a very rare syndrome consisting of microcephaly with facial dysmorphism, spondylometaepiphyseal dysplasia and severe intellectual deficit

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with Hall-Riggs syndrome, sourced from HPO and Orphanet clinical annotations.

Wide mouthMicrocephalyEpicanthusHypertelorismWide nasal bridgeProminent noseAnteverted naresAbnormal dental enamel morphologyDelayed eruption of teethPlatyspondylyAbnormal metaphysis morphologyBrachydactylySeizureAbsent speechJoint stiffnessFailure to thriveNausea and vomitingCoarse hairSlow-growing hairScoliosisDownturned corners of mouthDelayed skeletal maturationShort statureAbnormal epiphysis morphologyLimb undergrowthSevere intellectual disabilitySevere global developmental delayThick vermilion borderThick hair

Classification & Codes

MeSH Code

C535623

Orphanet Code

ORPHA:2107
Hall-Riggs syndrome
MeSHC535623
OrphanetORPHA:2107
Treatments0 drug(s)
Symptoms on record29 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO